Literature DB >> 11106420

Oxidative degradation of bilirubin produces vasoactive compounds.

K R Kranc1, G J Pyne, L Tao, T D Claridge, D A Harris, T A Cadoux-Hudson, J J Turnbull, C J Schofield, J F Clark.   

Abstract

Subarachnoid haemorrhage is often followed by haemolysis and concomitant oxidative stress, and is frequently complicated by pathological vasoconstriction or cerebral vasospasm. It is known that upregulation of haem oxygenase (HO-1) is induced by oxidative stress and results in release of biliverdin and bilirubin (BR), which are scavengers of reactive oxygen species (ROS). Here we report biomimetic studies aimed at modelling pathological conditions leading to oxidative degradation of BR. Oxidative degradation products of BR, formed by reaction with hydrogen peroxide (an ROS model system), demonstrated biological activity by stimulating oxygen consumption and force development in vascular smooth muscle from porcine carotid artery. Analogous biological activity was observed with vasoactive cerebrospinal fluid from subarachnoid haemorrhage patients. Three degradation products of BR were isolated: two were assigned as isomeric monopyrrole (C9H11N2O2) derivatives, 4-methyl-5-oxo-3-vinyl-(1, 5-dihydropyrrol-2-ylidene)acetamide and 3-methyl-5-oxo-4-vinyl-(1, 5-dihydropyrrol-2-ylidene)acetamide and the third was 4-methyl-3-vinylmaleimide (MVM), a previously isolated photodegradation product of biliverdin. Possible mechanisms of oxidative degradation of BR are discussed. Tentative assignment of these structures in the cerebrospinal fluid (CSF) of cerebral vasospasm patients has been made. It is proposed that one or more of the degradation products of biliverdin or bilirubin are involved in complications such as vasospasm and or pathological vasoconstriction associated with haemorrhage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106420     DOI: 10.1046/j.1432-1327.2000.01812.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

Review 1.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Bilirubin oxidation end products directly alter K+ channels important in the regulation of vascular tone.

Authors:  Shangwei Hou; Rong Xu; Joseph F Clark; William L Wurster; Stefan H Heinemann; Toshinori Hoshi
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

Review 3.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF.

Authors:  Gail J Pyne-Geithman; Sunil G Nair; Danielle N Caudell; Joseph F Clark
Journal:  Front Biosci       Date:  2008-01-01

5.  Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.

Authors:  W L Wurster; G J Pyne-Geithman; I R Peat; J F Clark
Journal:  Acta Neurochir Suppl       Date:  2008

6.  Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.

Authors:  R E Ayer; J H Zhang
Journal:  Acta Neurochir Suppl       Date:  2008

7.  A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system.

Authors:  Matthew C Loftspring; Craig Hansen; Joseph F Clark
Journal:  Med Hypotheses       Date:  2009-08-28       Impact factor: 1.538

8.  Bilirubin and its oxidation products damage brain white matter.

Authors:  Katarina Lakovic; Jinglu Ai; Josephine D'Abbondanza; Asma Tariq; Mohammed Sabri; Abdullah K Alarfaj; Punarjot Vasdev; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

9.  Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.

Authors:  J Marc Simard; E Francois Aldrich; David Schreibman; Robert F James; Adam Polifka; Narlin Beaty
Journal:  J Neurosurg       Date:  2013-09-13       Impact factor: 5.115

10.  Bilirubin oxidation products, oxidative stress, and intracerebral hemorrhage.

Authors:  J F Clark; M Loftspring; W L Wurster; S Beiler; C Beiler; K R Wagner; G J Pyne-Geithman
Journal:  Acta Neurochir Suppl       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.